Download PDF
Diabetologie und Stoffwechsel 2007; 2(3): 175-182
DOI: 10.1055/s-2007-960657
Übersicht

© Georg Thieme Verlag Stuttgart · New York

Kardiale autonome diabetische Neuropathie

Cardiac Autonomic Diabetic Neuropathy (CADN)M. Schönauer1 , C. Kautz2 , A. Thomas3 , J. Niebauer4
  • 1Diabetologische Schwerpunktpraxis, Leipzig
  • 2Universitätsklinik Leipzig, Medizinische Fakultät, Leipzig
  • 3DIA REAL GmbH, Dresden
  • 4Universitätsinstitut für präventive und rehabilitative Sportmedizin, Medizinische Privatuniversität Salzburg
Further Information

Publication History

2007

2007

Publication Date:
10 May 2007 (online)

Also available at
    Permissions and Reprints

Die autonome diabetische Neuropathie (ADN)

Die autonome diabetische Neuropathie (ADN) ist eine häufige und ernst zu nehmende Komplikation des Diabetes mellitus. Sie kann als klinisch symptomatische oder subklinische Erkrankung alle vegetativ innervierten Organe und Organsysteme, wie zum Beispiel den Gastrointestinaltrakt, den Urogenitaltrakt oder das kardiovaskuläre System betreffen [1]. Das volle Bild einer ADN mit Multiorganbefall tritt jedoch nur selten auf. Klinisch ist sie meist durch ein heterogenes Symptomenmuster an unterschiedlichen Organsystemen gekennzeichnet, was zu Fehldiagnosen führen kann [2] [3]. Aufgrund einer Koinzidenz von etwa 50 % sollte bei Nachweis einer sensomotorischen diabetischen Neuropathie stets auch an die Möglichkeit einer ADN gedacht werden [4].

Beziehungen bestehen außerdem zu anderen diabetischen Langzeitkomplikationen wie Nephropathie und Retinopathie [5].

Literatur

  • 1 American Diabetes Association, American Academy of Neurology . Consensus statement: Report and recommendations of the San Antonio conference on diabetic neuropathy.  Diabetes Care. 1988;  11 592-597
    Google Scholar
  • 2 Vinik A I, Maser R E, Mitchell B D. et al . Diabetic autonomic neuropathy.  Diabetes Care. 2003;  26 1553-1579
    CrossrefGoogle Scholar
  • 3 Pfeifer M A, Weinberg C R, Cook D L. et al . Autonomic neural dysfunction in recently diagnosed diabetic subjects.  Diabetes Care. 1984;  7 447-453
    Google Scholar
  • 4 Ziegler D, Dannehl K, Mühlen H. et al . Prevalence of cardiovascular autonomic dysfunction assessed by spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses at various stages of diabetic neuropathy.  Diabet Med. 1992;  9 806-814
    CrossrefGoogle Scholar
  • 5 Haslbeck M, Luft D, Neundörfer B. et al .Diagnose, Therapie und Verlaufskontrolle der autonomen diabetischen Neuropathie. Evidenzbasierte Diabetes-Leitlinie DDG. Deutsche Diabetes-Gesellschaft. 1. Auflage 2002
    Google Scholar
  • 6 Maser R E, Mitchell B D, Vinik A I. et al . The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes. A meta-analysis.  Diabetes Care. 2003;  26 1895-1901
    CrossrefPubMedGoogle Scholar
  • 7 Ewing D J, Campbell I W, Clarke B F. The natural history of diabetic autonomic neuropathy.  Q J Med. 1980;  49 95-108
    Google Scholar
  • 8 Watkins P J, Mackay J D. Cardiac denervation in diabetic neuropathy.  Ann Intern Med. 1980;  92 304-307
    Google Scholar
  • 9 Schrödter D. Diabetes mellitus - eine kardiovaskuläre Erkrankung. 1. Auflage. UNI-MED, Bremen 2002
    Google Scholar
  • 10 Ewing D J, Campbell I W, Clarke B F. Heart rate changes in diabetes mellitus.  Lancet. 1981;  317 183-186
    CrossrefGoogle Scholar
  • 11 DCCT Research Group . The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT).  Diabetologia. 1998;  41 416-423
    CrossrefGoogle Scholar
  • 12 Kennedy W R, Navarro X, Goetz F C. et al . Effects of pancreatic transplantation on diabetic neuropathy.  N Engl J Med. 1990;  322 1031-1037
    Google Scholar
  • 13 Kennedy W R, Navarro X, Sutherland D E. Neuropathy profile of diabetic patients in a pancreas transplantation program.  Neurology. 1995;  45 773-780
    Google Scholar
  • 14 Ewing D J, Campbell I W, Clarke B F. Mortality in diabetic autonomic neuropathy.  Lancet. 1976;  1 601-603
    Google Scholar
  • 15 Gerritsen J, Dekker J M, TenVoorde B J. et al . Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease. The HOORN Study.  Diabetes Care. 2001;  24 1793-1798
    CrossrefPubMedGoogle Scholar
  • 16 Navarro X, Kennedy W R, Aeppli D. et al . Neuropathy and mortality in diabetes: influence of pancreas transplantation.  Muscle Nerve. 1996;  19 1009-1016
    CrossrefGoogle Scholar
  • 17 Katz A, Liberty I F, Porath A. et al . A simple bedside test of 1-minute heart rate variability during deep breathing as a prognostic index after myocardial infarction.  Am Heart J. 1999;  138 32-38
    CrossrefGoogle Scholar
  • 18 Luft D. Praxisleitfaden der diabetischen Polyneuropathie. 1. Auflage. UNI-MED Verlag, Bremen 2000
    Google Scholar
  • 19 Valensi P, Sachs R N, Harfouche B. et al . Predictive value of cardiac autonomic neuropathy in diabetic patients with or without silent myocardial ischemia.  Diabetes Care. 2001;  24 339-343
    CrossrefGoogle Scholar
  • 20 O'Brien I A, O'Hare J P, Lewin I G. et al . The prevalence of autonomic neuropathy in insulin-dependent diabetes mellitus: a controlled study based on heart rate variability.  Q J Med. 1986;  61 957-967
    Google Scholar
  • 21 Clarke B F, Ewing D J, Campbell I W. Diabetic autonomic neuropathy.  Diabetologia. 1979;  17 195-212
    CrossrefGoogle Scholar
  • 22 Maser R E, Pfeifer M A, Dorman J S. et al . Diabetic autonomic neuropathy and cardiovascular risk. Pittsburgh Epidemiology of Diabetes Complications Study III.  Arch Intern Med. 1990;  150 1218-1222
    CrossrefGoogle Scholar
  • 23 Cohen J A, Jeffers B W, Faldut D. et al . Risks for sensorimotor peripheral neuropathy and autonomic neuropathy in non-insulin-dependent diabetes mellitus (NIDDM).  Muscle Nerve. 1998;  21 72-80
    CrossrefGoogle Scholar
  • 24 Spallone V, Maiello M R, Cicconetti E. et al . Autonomic neuropathy and cardiovascular risk factors in insulin-dependent and non-insulin-dependent diabetes.  Diabetes Res Clin Pract. 1997;  34 169-179
    CrossrefGoogle Scholar
  • 25 Colhoun H M, Francis D P, Rubens M B. et al . The association of heart-rate variability with cardiovascular risk factors and coronary artery calcification: A study in type 1 diabetic patients and the general population.  Diabetes Care. 2001;  24 1108-1114
    CrossrefGoogle Scholar
  • 26 Simonson D C. Etiology and prevalence of hypertension in diabetic patients.  Diabetes Care. 1988;  11 812-827
    Google Scholar
  • 27 Muller J E, Tofler G H, Stone P H. Circadian variation and triggers of onset of acute cardiovascular disease.  Circulation. 1989;  79 733-743
    Google Scholar
  • 28 The Task Force of the European Society of Cardiology and the North American Society of Pacing Electrophysiology [ESC and NASPE] . Heart rate variability - standards of measurement, physiological interpretation, and clinical use.  Circulation. 1996;  93 1043-1065
    Google Scholar
  • 29 Esperer H D. Physiologische Grundlagen und pathologische Aspekte der Herzfrequenzvariabilität beim Menschen.  Herzschr Elektrophys. 1994;  5 (Suppl 2) 1-10
    Google Scholar
  • 30 Karemaker J M, Lie K I. Heart rate variability: a telltale of health or disease. Editorial.  Eur Heart J. 2000;  21 435-437
    CrossrefGoogle Scholar
  • 31 Cheng T O. Decreased heart rate variability as a predictor for sudden death was known in China in the third century A.D. Letter to the editor.  Eur Heart J. 2000;  21 2081-2082
    CrossrefGoogle Scholar
  • 32 Scherer P. Parameter der Herzfrequenzvariabilität im Zeitbereich.  Herzschr Elektrophys. 1994;  5 15-18
    Google Scholar
  • 33 Ewing D J, Martyn C N, Young R J. et al . The value of cardiovascular autonomic function tests: 10 years experience in diabetes.  Diabetes Care. 1985;  8 (Suppl 2) 491-498
    CrossrefPubMedGoogle Scholar
  • 34 Meesmann M, Boese J, Scharf R. Vergleich der Methoden zur Bestimmung der Herzfrequenzvariabilität.  Herzschr Elektrophys. 1994;  5 (Suppl 2) 25-29
    Google Scholar
  • 35 Wegschneider K. Statistische Zeitreihenmodelle und Herzfrequenzvariabilität.  Herzschr Elektrophys. 1994;  5 (Suppl 2) 11-14
    Google Scholar
  • 36 Walbrecht P, Cohen R J. Estimation of heart rate power spectrum bands from real-world data: dealing with ectopic beats and noisy data.  Comput Cardiol. 1988;  15 311-314
    Google Scholar
  • 37 Howorka K, Pumprla J, Schabmann A. Optimal parameters of short-term heart rate spectrogram for routine evaluation of diabetic cardiovascular autonomic neuropathy.  J Auton Nerv Syst. 1998;  69 104-172
    Google Scholar
  • 38 Bigger Jr J T, Fleiss J L, Rolnitzky L M. et al . Stability over time of heart period variability in patients with previous myocardial infarction and ventricular arrhythmias. The CAPS and ESVEM investigators.  Am J Cardiol. 1992;  69 718-723
    CrossrefGoogle Scholar
  • 39 Akselrod S, Gordon D, Ubel F A. et al . Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control.  Science. 1981;  213 220-222
    CrossrefGoogle Scholar
  • 40 Pomeranz B, Macaulay R J, Caudill M A. et al . Assessment of autonomic function in humans by heart rate spectral analysis.  Am J Physiol. 1985;  248 H 151-H 153
    Google Scholar
  • 41 Malliani A, Pagani M, Lombardi F. et al . Cardiovascular neural regulation explored in the frequency domain.  Circulation. 1991;  84 1482-1492
    Google Scholar
  • 42 Rimoldi O, Pierini S, Ferrari A. et al . Analysis of short-term oscillations of R-R and arterial pressure in conscious dogs.  Am J Physiol. 1990;  258 H 967-H 976
    Google Scholar
  • 43 Montano N, Ruscone T G, Porta A. et al . Power spectrum analysis of heart rate variability to assess the changes in sympathovagal balance during graded orthostatic tilt.  Circulation. 1994;  90 1826-1831
    CrossrefPubMedGoogle Scholar
  • 44 Hayano J, Sakakibara Y, Yamada A. et al . Acuracy of assessment of cardiac vagal tone by heart rate variability in normal subjects.  Am J Cardiol. 1991;  67 199-204
    CrossrefGoogle Scholar
  • 45 Hedman A E, Tahvanainen K U, Hartikainen J E. et al . Effect of sympathetic modulation and sympatho-vagal interaction on heart rate variability in anaesthetized dogs.  Acta Physiol Scand. 1995;  155 205-214
    Google Scholar
  • 46 Pagani M, Lombardi F, Guzzetti S. et al . Power spectral density of heart rate variability as an index of sympatho-vagal interaction in normal and hypertensive subjects.  J Hypertens Suppl. 1984;  2 S 383-S 385
    Google Scholar
  • 47 Kamath M V, Ghista D N, Fallen E L. et al . Heart rate variability power spectrogram as a potential noninvasive signature of cardiac regulatory system response, mechanisms, and disorders.  Heart Vessels. 1987;  3 33-41
    CrossrefGoogle Scholar
  • 48 Sroka K. Vagale Depression und ischämische Herzkrankheit.  Herz Kreisl. 1998;  30 437-443
    Google Scholar
  • 49 Brüggemann T, Weiß D, Andresen D. Spektralanalyse zur Beurteilung der Herzfrequenzvariabilität.  Herzschr Elektrophys. 1994;  5 (Suppl 2) 19-24
    Google Scholar
  • 50 Bigger Jr J T, Fleiss J L, Steinman R C. et al . Frequency domain measures of heart period variability and mortality after myocardial infarction.  Circulation. 1992;  85 164-171
    CrossrefGoogle Scholar
  • 51 Pagani M. Heart rate variability and autonomic diabetic neuropathy.  Diabetes Nutr Metab. 2000;  13 341-346
    Google Scholar
  • 52 Tsuji H, Venditti Jr F J, Manders E S. et al . Reduced heart rate variability and mortality risk in an elderly cohort.  Circulation. 1994;  90 878-883
    CrossrefGoogle Scholar
  • 53 Rathmann W, Ziegler D, Jahnke M. et al . Mortality in diabetic patients with cardiovascular autonomic neuropathy.  Diabet Med. 1993;  10 664-671
    CrossrefGoogle Scholar
  • 54 Wolf M M, Varigos G A, Hunt D. et al . Sinus arrhythmia in acute myocardial infarction.  Med J Aust. 1978;  2 52-53
    Google Scholar
  • 55 Nolan J, Batin P D, Andrews R. et al . Results of the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-Heart).  Circulation. 1998;  98 1510-1516
    CrossrefGoogle Scholar
  • 56 Kleiger R E, Miller J P, Bigger Jr J T. et al . Decreased heart rate variability and its association with increased mortality after acute myocardial infarction.  Am J Cardiol. 1987;  59 256-262
    CrossrefGoogle Scholar
  • 57 Malik M, Farrell T, Cripps T. et al . Heart rate variability in relation to prognosis after myocardial infarction: selection of optimal processing techniques.  Eur Heart J. 1989;  10 1060-1074
    Google Scholar
  • 58 Cripps T R, Malik M, Farrell T G. et al . Prognostic value of reduced heart rate variability after myocardial infarction: clinical evaluation of a new analysis method.  Br Heart J. 1991;  65 14-19
    Google Scholar
  • 59 La Rovere M T, Bigger Jr J T, Marcus F I. et al . Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators.  Lancet. 1998;  351 478-484
    CrossrefGoogle Scholar
  • 60 Ponikowski P, Anker S D, Chua T P. et al . Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.  Am J Cardiol. 1997;  79 1645-1650
    CrossrefGoogle Scholar
  • 61 Makikallio T H, Huikuri H V, Hintze U. et al . Fractal analysis and time- and frequency-domain measures of heart rate variability as predictors of mortality in patients with heart failure.  Am J Cardiol. 2001;  87 178-182
    CrossrefGoogle Scholar
  • 62 Klingenheben T, Credner S, Grönefeld G. et al . Kardialer autonomer Tonus zur Risikostratifikation nach Myokardinfarkt: Ergebnisse einer prospektiven Langzeitstudie bei 411 konsekutiven Patienten.  Z Kardiol. 1999;  88 400-409
    CrossrefGoogle Scholar
  • 63 De Ferrari G M, Vanoli E, Curcuruto P. et al . Prevention of life-threatening arrhythmias by pharmacologic stimulation of the muscarinic receptors with oxotremorine.  Am Heart J. 1992;  124 883-890
    CrossrefGoogle Scholar
  • 64 Gold D R, Litonjua A, Schwartz J. et al . Ambient pollution and heart rate variability.  Circulation. 2000;  101 1267-1273
    Google Scholar
  • 65 Roche F, Gaspoz J M, Court-Fortune I. et al . Screening of obstructive sleep apnea syndrome by heart rate variability analysis.  Circulation. 1999;  100 1411-1415
    Google Scholar
  • 66 Kazuma N, Otsuka K, Matsuoka I. et al . Heart rate variability during 24 hours in asthmatic children.  Chronobiol Int. 1997;  14 597-606
    Google Scholar
  • 67 Coelho L, Saraiva S, Guimaraes H. et al . Autonomic function in chronic liver disease assessed by Heart Rate Variability Study.  Rev Port Cardiol. 2001;  20 25-36
    Google Scholar
  • 68 Leicht A S, Allen G D, Hoey A J. Influence of intensive cycling training on heart rate variability during rest and exercise.  Can J Appl Physiol. 2003;  28 898-909
    CrossrefGoogle Scholar
  • 69 Garet M, Tournaire N, Roche F. et al . Individual interdependence between nocturnal ANS activity and performance in swimmers.  Med Sci Sports Exerc. 2004;  36 2112-2118
    Google Scholar
  • 70 Agelink M W, Malessa R, Baumann B. et al . Standardized tests of heart rate variability: normal ranges obtained from 309 healthy humans, and effects of age, gender, and heart rate.  Clin Auton Res. 2001;  11 99-108
    Google Scholar
  • 71 Ziegler D, Laux G, Dannehl K. et al . Assessment of cardiovascular autonomic function: age-related normal ranges and reproducibility of spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses.  Diabet Med. 1992;  9 166-175
    Google Scholar
  • 72 Evans J M, Ziegler M G, Patwardhan A R. et al . Gender differences in autonomic cardiovascular regulation: spectral, hormonal, and hemodynamic indexes.  J Appl Physiol. 2001;  91 2611-2618
    Google Scholar
  • 73 Wawryk A M, Bates D J, Couper J J. Power spectral analysis of heart rate variability in children and adolescents with IDDM.  Diabetes Care. 1997;  20 1416-1421
    CrossrefGoogle Scholar
  • 74 Ziegler D, Gries F A, Spüler M. et al . The epidemiology of diabetic neuropathy. Diabetic Cardiovascular Autonomic Neuropathy Multicenter Study Group.  J Diabetes Complications. 1992;  6 49-57
    CrossrefGoogle Scholar
  • 75 Chessa M, Butera G, Lanza G A. et al . Role of heart rate variability in the early diagnosis of diabetic autonomic neuropathy in children.  Herz. 2002;  27 785-790
    CrossrefGoogle Scholar
  • 76 Levitt N S, Stansberry K B, Wynchank S. et al . The natural progression of autonomic neuropathy and autonomic function tests in a cohort of people with IDDM.  Diabetes Care. 1996;  19 751-754
    CrossrefGoogle Scholar
  • 77 Howorka K, Pumprla J, Haber P. et al . Effects of physical training on heart rate variability in diabetic patients with various degrees of cardiovascular autonomic neuropathy.  Cardiovasc Res. 1997;  34 206-214
    CrossrefGoogle Scholar
  • 78 Singh J P, Larson M G, O'Donnell C J. et al . Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study).  Am J Cardiol. 2000;  86 309-312
    CrossrefPubMedGoogle Scholar
  • 79 DCCT Research Group . The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial (DCCT).  Diabetes. 1996;  45 1289-1298
    CrossrefGoogle Scholar
  • 80 Gaede P, Vedel P, Larsen N. et al . Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.  N Engl J Med. 2003;  348 383-393
    Google Scholar
  • 81 Ziegler D, Schatz H, Conrad F. et al . Effects of treatment with the antioxidant α-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study). Deutsche Kardiale Autonome Neuropathie.  Diabetes Care. 1997;  20 369-373
    Google Scholar
  • 82 Didangelos T P, Karamitsos D T, Athyros V G. et al . Effect of aldose reductase inhibition on cardiovascular reflex tests in patients with definite diabetic autonomic neuropathy over a period of 2 years.  J Diabetes Complications. 1998;  12 201-207
    CrossrefGoogle Scholar
  • 83 Okamoto H, Nomura M, Nakaya Y. et al . Effects of epalrestat, an aldose reductase inhibitor, on diabetic neuropathy and gastroparesis.  Intern Med. 2003;  42 655-664
    Google Scholar
  • 84 Kontopoulos A G, Athyros V G, Didangelos T P. et al . Effect of chronic quinapril administration on heart rate variability in patients with diabetic autonomic neuropathy.  Diabetes Care. 1997;  20 355-361
    Google Scholar
  • 85 Malik R A, Williamson S, Abbott C. et al . Effect of angiotensin-converting-enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: randomised double-blind controlled trial.  Lancet. 1998;  352 1978-1981
    CrossrefGoogle Scholar
  • 86 Ebbehoj E, Poulsen P L, Hansen K W. et al . Effects on heart rate variability of metoprolol supplementary to on going ACE-inhibitor treatment in type I diabetic ptients with abnormal albuminuria.  Diabetologia. 2002;  45 965-975
    CrossrefGoogle Scholar
  • 87 Schönauer M, Schreiner M, Niebauer J. et al . Einfluss der Stoffwechselverbesserung unter Pioglitazon auf die Herzfrequenzvariabilität bei Typ-2-Diabetikern: Ergebnisse der Praxisstudie ETAPP.  Dtsch Ärztebl Thüringen. 2004;  15 340-341
    Google Scholar
  • 88 Boulton A JM, Vinik A I, Arezzo J C. et al . Diabetic neuropathies, A statement by the American Diabetes Association.  Diabetes Care. 2005;  28 956-962
    CrossrefGoogle Scholar

Dr. M. Schönauer

Diabetologische Schwerpunktpraxis

August-Bebel-Str. 71

04275 Leipzig

Email: mschoenauer@web.de

      >